Pathogenic role of mast cells in experimental eosinophilic esophagitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 304, Issue 12, 2013, Pages

  Niranjan, Rituraj ^a   Mavi, Parm ^b   Rayapudi, Madhavi ^a   Dynda, Scott ^a   Mishra, Anil ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

5 bromodeoxyuridine; Allergen; Eosinophilic esophagitis; Hyperplasia; Hypertrophy; Mast cells; Muscular mucosa

Indexed keywords

ALLERGEN; INTERLEUKIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPERPLASIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL MASTOCYTOSIS; ESOPHAGUS DISEASE; ESOPHAGUS MUCOSA; LAMINA PROPRIA; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

5′-BROMODEOXYURIDINE; ALLERGEN; EOSINOPHILIC ESOPHAGITIS; HYPERPLASIA; HYPERTROPHY; MAST CELLS; MUSCULAR MUCOSA;

ALLERGENS; ANIMALS; ASPERGILLUS FUMIGATUS; CELL ENLARGEMENT; DISEASE MODELS, ANIMAL; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; ESOPHAGUS; HYPERPLASIA; MAST CELLS; MICE; MUCOUS MEMBRANE; MYOCYTES, SMOOTH MUSCLE;

EID: 84879147399     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00070.2013     Document Type: Article

References (32)

1. Abonia JP, Blanchard C, Butz BB, Rainey HF, Collins MH, Stringer K, Putnam PE, Rothenberg ME. Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol 126: 140-149, 2010.
2. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116: 536-547, 2006.
3. Blank U, Jouvin MH, Guerin-Marchand C, Kinet JP. [The highaffinity IgE receptor: lessons from structural analysis]. Med Sci 19: 63-69, 2003.
4. Blank U, Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 25: 266-273, 2004.
5. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 117: 1277-1284, 2006.
6. Brandt EB, Strait RT, Hershko D, Wang Q, Muntel EE, Scribner TA, Zimmermann N, Finkelman FD, Rothenberg ME. Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 112: 1666-1677, 2003.
7. Broide DH. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 108: S65-S71, 2001.
8. Dahinden CA, Geiser T, Brunner T, Vontscharner V, Caput D, Ferrara P, Minty A, Baggiolini M. Monocyte chemotactic protein 3 is a most effective basophiland eosinophil-activating chemokine. J Exp Med 179: 751-756, 1994.
9. Dellon ES, Chen X, Miller CR, Fritchie KJ, Rubinas TC, Woosley JT, Shaheen NJ. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol 106: 264-271, 2011.
10. Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: It's not just kid's stuff. Gastrointest Endosc 56: 260-270, 2002.
11. Furuta GT. Eosinophils in the esophagus: acid is not the only cause. J Pediatr Gastroenterol Nutr 26: 468-471, 1998.
12. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23: 749-786, 2005.
13. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 6: 135-142, 2005.
14. Justinich CJ, Ricci A Jr, Kalafus DA, Treem WR, Hyams JS, Kreutzer DL. Activated eosinophils in esophagitis in children: a transmission electron microscopic study. J Pediatr Gastroenterol Nutr 25: 194-198, 1997.
15. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2: 773-786, 2002.
16. Kawakami T, Kitaura J, Xiao W, Kawakami Y. IgE regulation of mast cell survival and function. Novartis Found Symp 271: 100-107; discussion 108-114, 145-151, 2005.
17. Lucendo AJ, Lucendo B. An update on the immunopathogenesis of eosinophilic esophagitis. Expert Rev Gastroenterol Hepatol 4: 141-148, 2010.
18. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol 114: 21-27, 2004.
19. Mavi P, Rajavelu P, Rayapudi M, Paul RJ, Mishra A. Esophageal functional impairments in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 302: G1347-G1355, 2012.
20. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 107: 83-90, 2001.
21. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 168: 2464-2469, 2002.
22. Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 103: 1719-1727, 1999.
23. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 125: 1419-1427, 2003.
24. Mishra A, Wang M, Pemmaraju VR, Collins MH, Fulkerson PC, Abonia JP, Blanchard C, Putnam PE, Rothenberg ME. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 134: 204-214, 2008.
25. Mulder DJ, Mak N, Hurlbut DJ, Justinich CJ. Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E-bearing intraepithelial mast cells. Histopathology 61: 810-822, 2012.
26. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 351: 940-941, 2004.
27. Rajavelu P, Rayapudi M, Moffitt M, Mishra A, Mishra A. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 302: G645-G654, 2012.
28. Reber LL, Marichal T, Galli SJ. New models for analyzing mast cell functions in vivo. Trends Immunol 33: 613-625, 2012.
29. Romagnani P, De Paulis A, Beltrame C, Annunziato F, Dente V, Maggi E, Romagnani S, Marone G. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 155: 1195-1204, 1999.
30. Sridhara S, Ravi K, Smyrk TC, Kita H, Kephart GM, Weiler CR, Katzka DA. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Clin Gastroenterol Hepatol 10: 735-741, 2012.
31. Teitelbaum JE, Fox VL, Twarog FJ, Nurko S, Antonioli D, Gleich G, Badizadegan K, Furuta GT. Eosinophilic esophagitis in children: Immunopathological analysis and response to fluticasone propionate. Gastroenterology 122: 1216-1225, 2002.
32. Yu M, Tsai M, Tam SY, Jones C, Zehnder J, Galli SJ. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 116: 1633-1641, 2006.